Azelis has entered into an agreement to buy US-based Vigon International, expanding its footprint in the life sciences sector. Financial details of the transaction...
The long simmering discussion over whether manufacturers of Covid-19 vaccines should waive their intellectual property (IP) rights in hope of giving more people access to...
Europe wants to become the world’s first climate-neutral continent by 2050 and decouple its economic growth from the consumption of natural resources – this is what the...
Recent studies show that contract manufacturers for the pharmaceutical industry, so-called CDMOs (contract development and manufacturing organizations), have so far been...
EU Annex 1 which specifies guidance for the manufacture of sterile medicinal products is currently in the process of being rewritten. The current 16-page document will be...
Join the live webinar series and get a deep insight into the newest developments from Lanxess' Business Units which will highlight innovative product solutions.
